About miDiagnostics
miDiagnostics is a company based in Leuven (Belgium) founded in 2015. miDiagnostics has raised $112.75 million across 4 funding rounds from investors including Thermo Fisher Scientific, Imec and Johns Hopkins University. The company has 93 employees as of December 31, 2022. miDiagnostics offers products and services including nanoFluidic Processor, PCR Card, Reader, and Software. miDiagnostics operates in a competitive market with competitors including Biological Dynamics, Nanosphere, Anteo Tech, Genomic Vision and Aligned Bio, among others.
- Headquarter Leuven, Belgium
- Employees 93 as on 31 Dec, 2022
-
Sectors
Technology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Midiagnostics
-
Annual Revenue
$12.59 M (USD)0as on Dec 31, 2017
-
Net Profit
-$12.52 M (USD)2as on Dec 31, 2019
-
EBITDA
Not available
-
Total Equity Funding
$112.75 M (USD)
in 4 rounds
-
Latest Funding Round
$31.52 M (USD), Series D
Dec 03, 2024
-
Investors
Thermo Fisher Scientific
& 12 more
-
Employee Count
93
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of miDiagnostics
miDiagnostics offers a comprehensive portfolio of products and services, including nanoFluidic Processor, PCR Card, Reader, and Software.
Enables high-precision, fast testing at low cost for molecular diagnostics.
Facilitates sample processing with nanometer precision for accurate results.
Processes tests and provides results in under 30 minutes.
Supports protocols for lab information systems and result traceability.
People of miDiagnostics
Unlock access to complete
Unlock access to complete
Funding Insights of miDiagnostics
miDiagnostics has successfully raised a total of $112.75M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $31.52 million completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in miDiagnostics
miDiagnostics has secured backing from 13 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Thermo Fisher Scientific, Imec and Johns Hopkins University.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Alychlo is engaged in investment activities supporting entrepreneurial dreams.
|
Locked | Locked | Locked | |
|
Pamica is recognized as a growing industrial and service conglomerate.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for miDiagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by miDiagnostics
Investment portfolio details for miDiagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - miDiagnostics
Detailed financials for miDiagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Midiagnostics Comparisons
Peer comparison for miDiagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of miDiagnostics
miDiagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biological Dynamics, Nanosphere, Anteo Tech, Genomic Vision and Aligned Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Proprietary lab-on-chip platform for nanoparticle isolation is offered.
|
|
| Locked | Locked | Locked |
Diagnostic tests for personalized medicine targeting infections are provided.
|
|
| Locked | Locked | Locked |
Coupling reagents are developed for biomolecules immobilization on surfaces.
|
|
| Locked | Locked | Locked |
Single DNA molecules are analyzed via nanotechnology for cancer diagnostics.
|
|
| Locked | Locked | Locked |
Nanowire-based sensors and alignment technologies are provided for molecular detection.
|
Detailed competitors of miDiagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Midiagnostics
Complete news archive for miDiagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about miDiagnostics
miDiagnostics was founded in 2015.
miDiagnostics is headquartered in Leuven, Belgium. It is registered at Leuven, Flemish Brabant, Belgium.
Katleen Verleysen is the current CEO of miDiagnostics.
miDiagnostics is a funded company, having raised a total of $112.75M across 4 funding rounds to date.
As of Dec 31, 2022, the latest employee count at miDiagnostics is 93.
Annual revenue of miDiagnostics is $12.59M as on Dec 31, 2017.
MiDiagnostics was founded in 2015 as a joint venture between IMEC and Johns Hopkins University, based in Leuven, Belgium. Disposable chips are created using immunochemistry and nanotechnology to analyze biomarkers from a single blood drop for diagnosing cancer, infectious diseases, and cardiometabolic conditions like diabetes and cholesterol monitoring. Integration with an app enables data sharing with physicians and caregivers, and a consumer device is also offered.
miDiagnostics's top competitors include Biological Dynamics, Anteo Tech and Nanosphere.
miDiagnostics offers nanoFluidic Processor, PCR Card, Reader, and Software.
miDiagnostics has 13 investors. Key investors include Thermo Fisher Scientific, Imec, Johns Hopkins University, PMV, and VLAIO.